Katarzyna Jóźwiak

6PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial.

Monika Graeser, Oleg Gluz, Peter Schmid

|Jun 23, 2025
Night Shift Work and Risk of Melanoma: A Prospective Cohort Study among 59,384 Female Nurses in the Netherlands.

Linske de Bruijn, Henriëtte M van Duijne, Roel C H Vermeulen

|Sep 06, 2024
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer.

A V M Burger, C W Duinkerken, K E van Sluis

|Nov 16, 2023
Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors: A PanCareSurFup Study.

Emma J Heymer, Katarzyna Jóźwiak, Leontien C Kremer

|Feb 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.

Nadia Harbeck, Ulrike A Nitz, Matthias Christgen

|Aug 10, 2022
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.

Simone de Vries, Miriam L Haaksma, Katarzyna Jóźwiak

Pageof 1